Browsing by Subject

2023 GEIS Guidelines for gastrointestinal stromal tumors

Asencio, Jose Manuel; López-Guerrero, José Antonio; Rubió-Casadevall, Jordi; BAGUE, SILVIA; Martin-Broto, Javier; Serrano, Cesar (SAGE Publications, 2023)

A 24-month updated analysis of the comparative effectiveness of ZUMA-5 (axi-cel) vs. SCHOLAR-5 external control in relapsed/refractory follicular lymphoma

Palomba, M. Lia; Ghione, Paola; Patel, Anik R.; Nahas, Myrna; Beygi, Sara; Hatswell, Anthony; Bobillo Varela, Sabela (Taylor & Francis, 2023-02)

A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy

Elez Fernandez, Mª Elena; Mulet Margalef, Núria; Sanso Martinez, Miriam; Mancuso, Francesco Mattia; Ros Montañá, Fco. Javier; Argilés Martinez, Guillem; Martini, Giulia; Sanz Garcia, Enrique; Baraibar Argota, Iosune; Salva Ballabrera, Francesc; Noguerido Castro, Alba; Cuadra-Urteaga, Jose Luis; Fasani, Roberta; Garcia Rodriguez, Ariadna; Jiménez Catalan, Juan José; Aguilar, Susana; Hernandez Losa, Javier; Braña Garcia, Irene; Nuciforo, Paolo Giovanni; Tabernero Caturla, Josep; Salazar, Ramón; Vivancos Prellezo, Ana; Landolfi, Stefania; Comas Navarro, Raquel; Ruiz Pace, Fiorella; Dienstmann, Rodrigo (MDPI, 2022-12-21)

A first-in-human study of the anti-LAG-3 antibody favezelimab plus pembrolizumab in previously treated, advanced microsatellite stable colorectal cancer

Garralda Cabanas, Elena; Sukari, Ammar; Lakhani, Nehal; Patnaik, Amita; Lou, Yanyan; Im, Seock-Ah (Elsevier, 2022-12)

A Phase 1 Drug-Drug Interaction Study Between Brigatinib and the CYP3A Substrate Midazolam in Patients With ALK-Positive or ROS1-Positive Solid Tumors

Hanley, Michael J; D’Arcangelo, Manolo; Felip Font, Enriqueta; Garrido, Pilar; Zhu, Jiaxi; Ye, Meng (Wiley, 2023-05)

A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors

Choudhury, Atish D.; Higano, Celestia; Cook, Natalie; Rathkopf, Dana E.; Wisinski, Kari; Martín Liberal, Juan Jesús; de Bono, Johann S (American Association for Cancer Research, 2022-06-01)

A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors

Hanna, Glenn; Stathis, Anastasios; López Miranda, Elena ; Racca Bussano, Fabricio; Quon, Doris; Leyvraz, Serge; GARRALDA, Elena (American Association for Cancer Research, 2023-09-14)

A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study

Español-Rego, Marta; Fernández‑Martos, Carlos; Elez, Elena; Foguet Coll, Carles; Pedrosa Eguílaz, Leire; Rodríguez, Nuria (Springer, 2023-04)

A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer

Jones, Robert; Plummer, Ruth; Carter, Louise; Roda, Desamparados; Garralda Cabanas, Elena; Moreno, Victor (American Association for Cancer Research, 2023-01-17)

A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer

Van Cutsem, Eric; GARRALDA, Elena; Tai, David; de Braud, Filippo Guglielmo Maria; Geva, Ravit; Elez, Elena ; Tabernero, Josep (Oxford University Press, 2023-03)

A phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prostate cancer

Carles Galceran, Joan; Chowdhury, Simon; McGregor, Bradley; Merseburger, Axel; Agarwal, Neeraj; Azad, Arun (Future Medicine, 2022-03)

A plain language summary of results from the GARNET study of dostarlimab in patients with endometrial cancer

Tinker, Anna; Mathews, Cara; Press, Joshua; OAKNIN, ANA; Gilbert, Lucy; Brown, Jubilee (Future Medicine, 2023-08)

A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial)

Argilés Martinez, Guillem; Mulet Margalef, Nuria; Valladares-Ayerbes, Manuel; Viéitez, Jose Maria; Grávalos, Cristina; García-Alfonso, Pilar; Tabernero, Josep (Elsevier, 2022-12)

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer

Klochikhin, Arkadiy; Leboulleux, Sophie; Isaev, Pavel; Badiu, Corin; Robinson, Bruce; Capdevila Castillon, Jaume (Mary Ann Liebert, 2022-05)

A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)

Monk, Bradley J.; Parkinson, Christine; Lim, Myong Cheol; O’Malley, David M.; Oaknin Benzaquen, Ana Mazaltob; Wilson, Michelle (Lippincott Williams & Wilkins, 2022-12-01)

A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients

Toledano, Marta; Gómez España, Maria Auxiliadora; Elez Fernandez, Mª Elena; Grávalos, Cristina; García-Alfonso, P.; Rodríguez, R.; Tabernero Caturla, Josep (Elsevier, 2023-03)

A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer

Callejo Perez, Ana; Bar, Jair; Berchem, Guy; Bazhenova, Lyudmila; Saintigny, Pierre; Felip Font, Enriqueta; Solomon, Benjamin (Wiley, 2022-07)

Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials

Chumsri, Saranya; Li, Zhuo; Serie, Daniel J.; Norton, Nadine; Mashadi-Hossein, Afshin; Tenner, Kathleen; Saura Manich, Cristina (Nature Research, 2022-05-24)

Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis

Arriola, Edurne; Gonzalez-Cao, Maria; Domine, Manuel; De Castro, Javier; Bernabé, Reyes; NAVARRO, ALEJANDRO; cobo, manuel (Springer, 2022-06)

Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial

Döhner, Hartmut; Symeonidis, Argiris; Deeren, Dries; Demeter, Judit; Sanz, Miguel A.; Anagnostopoulos, Achilles; Salamero García, Olga (Wolters Kluwer Health, 2021-08)

Scientia. Dipòsit d'Informació Digital del Departament de Salut